M

MITech Co Ltd
KOSDAQ:179290

Watchlist Manager
MITech Co Ltd
KOSDAQ:179290
Watchlist
Price: 7 990 KRW -1.36% Market Closed
Market Cap: 258.6B KRW
Have any thoughts about
MITech Co Ltd?
Write Note

MITech Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MITech Co Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
M
MITech Co Ltd
KOSDAQ:179290
Income from Continuing Operations
â‚©12.9B
CAGR 3-Years
25%
CAGR 5-Years
101%
CAGR 10-Years
N/A
Dentium Co Ltd
KRX:145720
Income from Continuing Operations
â‚©85.7B
CAGR 3-Years
21%
CAGR 5-Years
19%
CAGR 10-Years
N/A
B
Biodyne Co Ltd
KOSDAQ:314930
Income from Continuing Operations
-â‚©991.8m
CAGR 3-Years
39%
CAGR 5-Years
6%
CAGR 10-Years
N/A
J
Jeisys Medical Inc
KOSDAQ:287410
Income from Continuing Operations
â‚©28.4B
CAGR 3-Years
N/A
CAGR 5-Years
264%
CAGR 10-Years
N/A
C
Classys Inc
KOSDAQ:214150
Income from Continuing Operations
â‚©84.9B
CAGR 3-Years
21%
CAGR 5-Years
24%
CAGR 10-Years
N/A
L
Lutronic Corp
KOSDAQ:085370
Income from Continuing Operations
â‚©28.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

MITech Co Ltd
Glance View

Market Cap
258.6B KRW
Industry
Health Care

M.I.Tech Co., Ltd. develops and manufactures non-vascular stent system. The company is headquartered in Pyeongtaek, Gyeonggi-Do and currently employs 157 full-time employees. The company went IPO on 2018-11-29. is a Korea-based company mainly engaged in the manufacturing and sale of stents. Stents include biliary, esophagus, pyloric, large intestine, duodenal stents, and stents for sample and study, among others. The Company’s stents are sold under the brand names of CHOOSTENT and HANAROSTENT. In addition, the Company is engaged in the manufacture and sale of low frequency therapies, crushers and blood glucose meters. The firm distributes its products within the domestic market and to overseas markets.

Intrinsic Value
12 159.45 KRW
Undervaluation 34%
Intrinsic Value
Price
M

See Also

What is MITech Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
12.9B KRW

Based on the financial report for Dec 31, 2023, MITech Co Ltd's Income from Continuing Operations amounts to 12.9B KRW.

What is MITech Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
101%

Over the last year, the Income from Continuing Operations growth was -41%. The average annual Income from Continuing Operations growth rates for MITech Co Ltd have been 25% over the past three years , 101% over the past five years .

Back to Top